Intraportally delivered GLP-1, in the presence of hyperglycemia induced via peripheral glucose infusion, does not change whole body glucose utilization.

Johnson KM, Edgerton DS, Rodewald T, Scott M, Farmer B, Neal D, Cherrington AD
Am J Physiol Endocrinol Metab. 2008 294 (2): E380-4

PMID: 18056788 · DOI:10.1152/ajpendo.00642.2007

MeSH Terms (13)

Animals Blood Glucose Dogs Enzyme-Linked Immunosorbent Assay Female Glucagon Glucagon-Like Peptide 1 Glucose Hyperglycemia Infusions, Intravenous Insulin Liver Circulation Male

Connections (3)

This publication is referenced by other Labnodes entities: